Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

Ke Lin, Ba D. Nguyen, David S. Ettinger, Bennett B. Chin

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

Original languageEnglish (US)
Pages (from-to)24-28
Number of pages5
JournalClinical nuclear medicine
Volume24
Issue number1
DOIs
StatePublished - Jan 1999

Keywords

  • In-111-Octreotide Scintigraphy
  • Somatostatin Therapy
  • Thymoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma'. Together they form a unique fingerprint.

Cite this